Literature DB >> 32291114

Cost-drivers of medical expenses in burn care management.

Shin-Yi Tsai1, Chon-Fu Lio2, Wei-Cheng Yao3, Chang-Pan Liu4, Shou-Chuan Shih5, Tina Yu-Ting Wang2, Kam-Hang Leong2, Fang-Ju Sun6, Chien-Feng Kuo7.   

Abstract

BACKGROUND: Profound differences exist in the cost of burn care globally, thus we aim to investigate the affected factors and to delineate a strategy to improve the cost-effectiveness of burn management.
METHODS: A retrospective analysis of 66 patients suffering from acute burns was conducted from 2013 to 2015. The average age was 26.7 years old and TBSA was 42.1% (±25.9%). We compared the relationship between cost and clinical characteristics.
RESULTS: The estimated cost of acute burn care with the following formula (10,000 TWD) = -19.80 + (2.67 × percentage of TBSA) + (124.29 × status of inhalation injury) + (147.63 × status of bacteremia) + (130.32 × status of respiratory tract infection).
CONCLUSION: The majority of the cost were associated with the use of antibiotics and burns care. Consequently, it is crucial to prevent nosocomial infection in order to promote healthcare quality and reduce in-hospital costs.
Copyright © 2020 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Burn injury; Cost; Medical services; Policy

Mesh:

Substances:

Year:  2020        PMID: 32291114     DOI: 10.1016/j.burns.2020.01.004

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  2 in total

1.  Emergency management for severe burn (EMSB) course for the nurses in Bangladesh: opportunity and way forward.

Authors:  Animesh Biswas; Koustuv Dalal; Rifat Ara Sawon; Cinderella Akbar Mayaboti; Saidur Rahman Mashreky
Journal:  Heliyon       Date:  2022-03-23

2.  The predisposing factors of AKI for prophylactic strategies in burn care.

Authors:  Shin-Yi Tsai; Chon-Fu Lio; Shou-Chuan Shih; Cheng-Jui Lin; Yu-Tien Chen; Chia-Meng Yu; Fang-Ju Sun; Chien-Feng Kuo; Xiaofeng Jia
Journal:  PeerJ       Date:  2020-09-29       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.